↓ Skip to main content

Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial

Overview of attention for article published in Supportive Care in Cancer, December 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
f1000
1 research highlight platform

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
141 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial
Published in
Supportive Care in Cancer, December 2013
DOI 10.1007/s00520-013-2075-1
Pubmed ID
Authors

Ying Guo, Desiree Jones, J. Lynn Palmer, Arthur Forman, Shaker R. Dakhil, Maria R. Velasco, Matthias Weiss, Paul Gilman, G. M. Mills, Stephen J. Noga, Cathy Eng, Michael J. Overman, Michael J. Fisch

Abstract

Chemotherapy-induced peripheral neuropathy is frequently a dose-limiting factor in cancer treatment and may cause pain and irreversible function loss in cancer survivors. We tested whether alpha-lipoic acid (ALA) could decrease the severity of peripheral neuropathy symptoms in patients undergoing platinum-based chemotherapy.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 141 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
Poland 1 <1%
Italy 1 <1%
Unknown 136 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 16%
Student > Ph. D. Student 16 11%
Student > Master 14 10%
Student > Doctoral Student 12 9%
Student > Bachelor 10 7%
Other 35 25%
Unknown 32 23%
Readers by discipline Count As %
Medicine and Dentistry 44 31%
Nursing and Health Professions 13 9%
Pharmacology, Toxicology and Pharmaceutical Science 12 9%
Agricultural and Biological Sciences 8 6%
Psychology 7 5%
Other 17 12%
Unknown 40 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2016.
All research outputs
#13,409,787
of 22,757,541 outputs
Outputs from Supportive Care in Cancer
#2,541
of 4,562 outputs
Outputs of similar age
#165,038
of 306,876 outputs
Outputs of similar age from Supportive Care in Cancer
#37
of 71 outputs
Altmetric has tracked 22,757,541 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,562 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 306,876 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.